AMNEAL PHARMACEUTICALS INC CLASS A (AMRX)
Sector: Health Care
Board of Directors
Director information for AMNEAL PHARMACEUTICALS INC CLASS A
Board as disclosed in the proxy statement filed March 25, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Chintu Patel | Co-Chief Executive Officer, Director | 54 | ["CEO, General Management, Commercial", "Manufacturing", "R&D, Scientific", "Regulatory"] | [] | 2026 |
| Chirag Patel | Co-Chief Executive Officer and President, Director | 59 | ["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Investment, Venture Capital", "International", "Regulatory"] | [] | 2026 |
| Deb Autor | Chief Policy Officer; Director | 59 | ["General Management", "Biosciences, Pharmaceuticals", "Regulatory", "Compliance", "Legal"] | [] | 2026 |
| Gautam Patel | Board Member; Director | 53 | ["Managing Director of Tarsadia Investments", "Led financial and strategic advisory efforts at Lazard", "Experience in M&A", "Knowledge of the Company\u2019s business and operations", "Deep experience in finance, corporate development, and healthcare investing"] | [] | 2026 |
| Jeff George | Managing Partner; Director | 52 | ["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Investment, Private Equity", "International"] | [] | 2026 |
| J. Kevin Buchi | Chair; Director | 70 | ["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Finance and Accounting", "International"] | ["remuneration and nominating committee", "audit committee"] | 2026 |
| John Kiely | Chair; Director | 67 | ["General Management", "Commercial", "Finance and Accounting", "M&A", "International"] | [] | 2026 |
| Paul Meister | Chairman of the Board of Directors | 73 | ["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "R&D, Scientific", "Investment, Venture Capital", "International"] | [] | 2026 |
| Shlomo Yanai | Board Member; Director | 73 | ["Former President and CEO at Teva Pharmaceutical Industries Ltd.", "Former CEO of Adama Industries", "Chairman of the Board of Lumenis Ltd.", "Senior advisor to Moelis & Company", "Various leadership positions in the Israel Defense Forces", "Graduate of Harvard Business School\u2019s AMP program", "Master of Public Administration from George Washington University", "B.A. degree from Tel Aviv University"] | [] | 2026 |
| Ted Nark | Chairman of West Edge Partners; Director | 67 | ["CEO", "General Management", "Commercial", "Corporate Development", "Business Development", "M&A", "Investment", "Venture Capital", "International"] | [] | 2026 |